Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride

scientific article published on May 1994

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0005-2736(94)90178-3
P698PubMed publication ID8172913
P5875ResearchGate publication ID15026174

P50authorGünter MüllerQ42676778
P2093author name stringW Kramer
F Girbig
U Gutjahr
S Kowalewski
D Hartz
H D Summ
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)278-290
P577publication date1994-05-01
P1433published inBiochimica et Biophysica ActaQ864239
P1476titleDifferential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride
P478volume1191

Reverse relations

cites work (P2860)
Q47692308A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful
Q36536205A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes
Q47754342A touching case of channel regulation: the ATP-sensitive K+ channel
Q36512883Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity
Q70958640Coexistence of two classes of glibenclamide-inhibitable ATP-regulated K+ channels in avian skeletal muscle
Q52657004Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.
Q44505758Effects of glimepiride on HbA(1c) and body weight in Type 2 diabetes: results of a 1.5-year follow-up study
Q71455827Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations
Q28363877Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels
Q35174221Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience
Q41750434Glimepiride. A review of its use in the management of type 2 diabetes mellitus
Q36899187Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus
Q36786594Glucose-induced sequential processing of a glycosyl-phosphatidylinositol-anchored ectoprotein in Saccharomyces cerevisiae
Q44000194Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action
Q71698249Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans
Q33508077Molecular identification and functional characterization of a mitochondrial sulfonylurea receptor 2 splice variant generated by intraexonic splicing
Q38646293New treatments for patients with type 2 diabetes mellitus
Q43157812Novel glimepiride derivatives with potential as double-edged swords against type II diabetes
Q26783199Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
Q51575264Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
Q37670198The role of glimepiride in the treatment of type 2 diabetes mellitus
Q78236765[Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents]

Search more.